Antibiotic nanoparticles attack respiratory infection and reduce drug side effects

13 marzo 2015

Treating respiratory disease is often difficult because drugs have to cross biological barriers such as respiratory tissue and mucosa, and must therefore be given in large quantities in order …
http://www.physnews.com/bio-medicine-news/cluster1167303834/

Volver